Micro-Energy Intervention Secures Tens of Millions in Pre-A Funding to Advance Innovative Vascular Interventional Platforms

Mar 19, 2024 11:29 CST Updated 11:29

Micro-Energy Medical

Vascular Interventional Device Manufacturer

Source: Heart Future; Editor: Seven Kite

Reprint Requirements: If the source of the article is indicated at the beginning of the text, it can be reprinted directly.

Heart Future

Recently,Micro-Energy Medical Technology (Hangzhou) Co., Ltd.(hereinafter referred to as "Micro-Energy Medical")Announcement CompletedTens of Millions of YuanPre-A Round Financing. This round of investment was led byTaiyu InvestmentLead investment,Shenzhen Guochuang Qinzhi Angel FundAndHuagai CapitalFollow-up Investment,Hanyu CapitalContinuously serve as the exclusive financial advisor.

This round of financing also follows Micro-Energy Medical's acquisition in 2023.PwC CapitalTens of Millions of Angel Round InvestmentAnother financing within the next year. With the joint efforts of new and existing shareholders, the companyWill continue to intensify the development of active energy vascular interventional product matrix and new technologies.; Accelerate product clinical registration; Promote the industrialization and global implementation of the product.

# Market Overview

As the trend of aging population in China continues to worsen, the number of patients with vascular diseases is increasing. As a minimally invasive treatment method for vascular diseases that has emerged in recent years,Vascular interventional therapy has the advantages of minimal invasiveness, rapid recovery, and fewer complications compared to surgical open procedures.。The demand for vascular interventional medical devices in the downstream market is continuously rising., coupled with the introduction of a series of support measures at both the national and local levels, is accelerating the localization of high-end medical equipment in China.Vascular interventional medical devices made in China also face significant market opportunities.。

According to different treatment areas, vascular interventional devices can be divided into cardiovascular interventional devices, cerebrovascular interventional devices, aortic and peripheral vascular interventional devices.With the rise of local cardiovascular interventional device manufacturers, strengthened market promotion by companies, and enhanced doctor education,The penetration rate of coronary interventional medical device products will continue to increase, driving the rapid growth of the overall cardiovascular interventional medical device market.。

In addition, with the introduction of the "intervention without implant" treatment concept, it is expected that innovative products such as drug-coated balloons and embolectomy balloons will, to a certain extent, represent the future direction of coronary intervention treatments. The market for coronary interventional consumables still has enormous development potential and will, to a degree, drive the growth of the cardiovascular intervention market.It is estimated that by 2024, the market size of coronary interventional medical devices in China will reach 10.36 billion yuan, while the scale of cardiovascular interventional medical devices will reach 30 billion yuan.。

At present, China's coronary intervention market still shows an increasing trend year by year. With the deepening of population aging, it is expected that the number of interventional surgeries will continue to increase in the future. Meanwhile, the number of peripheral artery interventional surgeries in China is expected to grow rapidly with the launch of new devices. At the same time, the continuous increase in stent implantations leads to a growing number of complex cases.Investors also have a long-term positive outlook on device innovation companies in the pan-vascular intervention field.。

# About Micro-Energy Medical

Micro-Energy Medical is a company based inActive Energy Vascular Interventional DevicesAn innovative medical technology company with a focus on Micro-Energy Medical. The company was founded in 2021, with operations, production bases, and R&D offices in Hangzhou, Shenzhen, and Coburg, Germany.The core team is composed of senior experts from China and Germany.，Chinese TeamFrom Micro-Energy Medical, Mindray, Edan, Peking Union Medical College, The Chinese University of Hong Kong, etc., with multidisciplinary research and development experience;German TeamGathered top experts in the laser field. The founding team has rich capabilities in international strategic layout and business promotion.

Focusing on the field of active energy vascular intervention, Micro-Energy Medical has laid out its strategy for key indications with significant clinical needs.355nm Solid-State Pulsed Laser Vascular Ablation System, Differentiated Innovative Shock Wave Balloon System, Varicose Vein Laser Ablation System, and Laser Renal Artery Sympathetic Denervation System (RDN).All product lines are either globally leading or domestically首创.Among them, the varicose vein laser ablation system is expected to obtain domestic registration and be launched for sale by the end of 2024, while other product lines are also planned to enter the clinical trial stage one after another this year.

The company's official website offers the following products:

▲Source: Company's official website

As of the date of publication, the company's financing history is as follows:

# Global Leading Cardiovascular Device Company

Medtronic｜J&J MedTech|Boston ScientificBoston Scientific|

Edwards Lifesciences | Abbott Abbott｜

# Cardiovascular Device Companies Listed in China

#2023 China Approved Innovative Devices

China Cardiovascular Innovation Device List [2023 Review]

#2023 Medical Devices Entering the Innovation Pathway in China

XinQing Medical (NyokAssist Interventional Ventricular Assist System)

NorthX Bio (Cardiac Pulse Field Ablation)

Hanling Medical (Transcatheter Aortic Valve)

# Other Unlisted/Start-up Cardiovascular Companies